Acknowledgements
U-BIOPRED has received funding from the Innovative Medicines Initiative
(IMI) Joint Undertaking under grant agreement no. 115010, resources of
which are composed of financial contributions from the European Union’s
Seventh Framework Programme (FP7/2007–2013), and European Federation of
Pharmaceutical Industries and Associations (EFPIA) companies’ in-kind
contributions
(www.imi.europa.eu). KFC and
IMA are funded by UK Research and Innovation (UKRI). KFC is an Emeritus
Senior Investigator of the UK National Institute for Health Research
(NIHR). We acknowledge the contribution of the whole U-BIOPRED team as
listed below.